Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age
Clinical trial NCT01659086 · COMPLETED
Trial details
- NCT number
- NCT01659086
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-22
- Primary completion
- 2012-10-26
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.